My interview starts at 19.25 minutes in

Welcome!

Excellent work. And kudos for having the courage to take this on.

Excited to be part of this - funding for our upcoming phase 2 inhaled COVID vaccine trial

🎉👏 Congratulations! 👏🎉 CTN Investigator Dr. Fiona Smaill (McMaster University) has been awarded a CIHR grant for her Phase 2 trial to evaluate the safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans. hivnet.ubc.ca/investigators/…

MIRC’s Dr. Zhou Xing announced as this year’s CSI 2023 Cinader Award winner mirc.mcmaster.ca/mircs-dr-zhou-…

We are happy to announce that Dr. Fiona Smaill will be presenting her work on a novel inhaled COVID #vaccine at our upcoming #HealthResearchCaucus Luncheon! This exciting area of research could change the face of emerging pandemic threats. Find out more: rc-rc.ca/2023-annual-ge…

Great way to kick off #BIO2023 BIO Convention with Life Sciences Ontario Clinical Trials ON and OBIO. Great talk by Université d'Ottawa | University of Ottawa Dr. John Bell around 🇨🇦 investment & work to strengthen life science and bio manufacturing sector - including hubs. Genome Canada

#CSI2023 Bernhard Cinader Award winner Dr. Zhou Xing from McMaster University takes us on a trek through research and self discovery. Dr. Xing’s body of work has changed the landscape of respiratory mucosal immunity and TB research. Congratulations Dr. Xing 👏👏👏

Congratulations to Dr. Zhou Xing, the recipient of the Bernhard Cinader Award at this years #CSI2023 Canadian Society for Immunology! Zhou has been at the forefront of mucosal immunology research, developing innovative vaccine technologies that can induce memory innate immune responses in the lung.

Congratulations to my colleague and friend, Zhou Xing, for winning the Cinader Award at #CSI2023 for amazing achievements over his career, all the way from basic studies to testing mucosal vaccines in clinical trials! Very well deserved McMaster Immunology McMaster IIDR

Read more about Dr. Fiona Smaill's work on the aerosol vaccine here: ow.ly/Z9q450MwBBw

Tuberculosis is set to overtake Covid-19 as the world’s most deadly infectious disease, with medical experts warning its resurgence represents a “ticking timebomb” healthcare emergency." theweek.co.uk/news/science-h…

Update on our inhaled COVID vaccine trial. Ready to enrol healthy participants who have had COVID and at least 3 doses of a mRNA vaccine. Message me at [email protected]. I will put you in touch with the research coordinator. Results so far looking good - seeing immune responses

Thanks for all the interest in our inhaled COVID vaccine study. At the present we have enough participants for the next part of the Phase 1 study, but stay tuned for the upcoming Phase 2 study with sites in Hamilton, Ottawa and Halifax.

(Flu cases likely peaked, trends look a lot different than last winter) (stuff.co.nz/national/healt…)

Congrats to Dr. Komorowski, the inaugural recipient of the Association of Medical Microbiology and Infectious Disease Canada's Fiona Smaill Award This award recognizes his dedication to medical education, commitment & passion for marginalized populations & scholarship excellence

André Picard Canadian Medical Hall Fame Congratulations Dr. McGeer!!!

The Canadian Pandemic Preparedness Hub, co-led by McMaster University and Université d'Ottawa | University of Ottawa, has received more than $115 million in federal funding. Global Nexus will play a leading role in translating this investment into new vaccines, therapeutics, and technologies.👇 brighterworld.mcmaster.ca/articles/mcmas…